Interested in Thymosin Beta 4 Peptide Therapy?
Start with a quick, free consultation. Tell us what you're looking for, and our medical team confirms the best option for you and gets you started.
Call or text (323) 655-8220Our team replies fast during clinic hours · Serving LA since 2010.
TB-500 (thymosin beta-4) is not currently FDA-approved, although in July 2026 an FDA advisory committee voted to recommend allowing licensed pharmacies to compound it. At Cienega it is available by prescription only as part of combination peptide blends (such as BPC-157/TB-500), when appropriate, after a consult with our medical team. This page is for general education and is not medical advice.
Thymosin Beta-4 (TB-4) is a naturally occurring 43-amino-acid peptide found in many cells throughout the body, and among the more abundant proteins inside mammalian cells. A synthetic fragment sold as TB-500 corresponds to part of the TB-4 sequence. It is studied in cell biology, including how cells move and repair. TB-500 is not currently FDA-approved; in July 2026 an FDA advisory committee voted to recommend allowing licensed pharmacies to compound it. At Cienega it is available by prescription only, as part of combination peptide blends, after a consult.
Click on a question to see more
Thymosin Beta-4 is a naturally occurring 43-amino acid peptide found in many cells throughout the body. It is one of the more abundant intracellular proteins in mammalian cells and has been a subject of laboratory research, particularly regarding its role in cell structure and movement through its interaction with actin.
TB-4 (Thymosin Beta-4) refers to the full naturally occurring 43-amino acid peptide. TB-500 is the name commonly used for a synthetic peptide fragment that corresponds to a portion of the TB-4 sequence. The two terms are often discussed together in peptide literature but are not identical molecules.
Not yet. Neither Thymosin Beta-4 nor the synthetic fragment TB-500 is currently approved by the U.S. Food and Drug Administration. In July 2026, however, an FDA advisory committee voted to recommend allowing licensed pharmacies to compound TB-500, and that recommendation is now in the FDA's formal review process. Until then, these remain research compounds available by prescription only.
Your prescription is filled by a licensed U.S. 503A compounding pharmacy and prepared for you specifically after your provider consultation. We do not sell research-grade or gray-market peptides.
Cared for by our 13-person Los Angeles medical team. Meet your provider →
In-person, physician-supervised care at all three Cienega Medical clinics.